Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer
Philippe E. Spiess, John N. Greene, Robert J. Keenan, David Paculdo, G. Douglas Letson, John Peabody
Abstract
The alarming situation of the 2019 novel coronavirus disease (COVID‐19) is contrasted by the limited efforts to curb the spread and impact of the disease among patients with cancer. This commentary proposes a simple 5‐part strategy plus rapidly expanded use of telemedicine to anticipate and deal with COVID‐19 and, by extension, future epidemics in patients with cancer.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusDiseaseCancerIntensive care medicinePandemicTelemedicineCoronavirus InfectionsVirologyInfectious disease (medical specialty)Health carePathologyInternal medicineEconomic growthOutbreakEconomicsCOVID-19 and healthcare impactsEconomic and Financial Impacts of CancerCOVID-19 Clinical Research Studies